NasdaqCM - Nasdaq Real Time Price USD

T2 Biosystems, Inc. (TTOO)

Compare
0.5100 +0.0842 (+19.77%)
At close: 4:00 PM EST
0.5050 -0.00 (-0.98%)
After hours: 5:18 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,677.0000
7,193.0000
22,305.0000
28,058.0000
18,130.0000
Cost of Revenue
13,570.0000
15,363.0000
21,010.0000
20,703.0000
21,280.0000
Gross Profit
-5,893.0000
-8,170.0000
1,295.0000
7,355.0000
-3,150.0000
Operating Expense
35,762.0000
38,983.0000
56,340.0000
50,328.0000
38,206.0000
Operating Income
-41,655.0000
-47,153.0000
-55,045.0000
-42,973.0000
-41,356.0000
Net Non Operating Interest Income Expense
-3,188.0000
-5,343.0000
-6,084.0000
-7,484.0000
-5,504.0000
Other Income Expense
1,889.0000
2,419.0000
-874.0000
1,216.0000
62.0000
Pretax Income
-42,954.0000
-50,077.0000
-62,003.0000
-49,241.0000
-46,798.0000
Net Income Common Stockholders
-42,954.0000
-50,077.0000
-62,333.0000
-49,241.0000
-46,798.0000
Diluted NI Available to Com Stockholders
-42,954.0000
-50,077.0000
-62,333.0000
-49,241.0000
-46,798.0000
Basic EPS
-0.03
-19.19
-1.23k
-31.00
-39.00
Diluted EPS
-0.03
-19.19
-1.23k
-31.00
-39.00
Basic Average Shares
10,528.2030
2,609.9840
51.0030
1,588.6140
1,213.3140
Diluted Average Shares
10,528.2030
2,609.9840
51.0030
1,588.6140
1,213.3140
Total Operating Income as Reported
-41,655.0000
-49,664.0000
-55,196.0000
-42,973.0000
-41,356.0000
Total Expenses
49,332.0000
54,346.0000
77,350.0000
71,031.0000
59,486.0000
Net Income from Continuing & Discontinued Operation
-42,954.0000
-50,077.0000
-62,003.0000
-49,241.0000
-46,798.0000
Normalized Income
-44,361.0000
-52,991.0000
-61,090.0000
-50,251.0000
-46,798.0000
Interest Income
100.0000
--
8.0000
112.0000
14.0000
Interest Expense
3,188.0000
5,343.0000
6,084.0000
7,596.0000
5,518.0000
Net Interest Income
-3,188.0000
-5,343.0000
-6,084.0000
-7,484.0000
-5,504.0000
EBIT
-39,766.0000
-44,734.0000
-55,919.0000
-41,645.0000
-41,280.0000
EBITDA
-39,507.0000
-43,875.0000
-54,872.0000
-39,107.0000
-38,124.0000
Reconciled Cost of Revenue
13,570.0000
15,363.0000
21,010.0000
20,703.0000
21,280.0000
Reconciled Depreciation
259.0000
859.0000
1,047.0000
2,538.0000
3,156.0000
Net Income from Continuing Operation Net Minority Interest
-42,954.0000
-50,077.0000
-62,003.0000
-49,241.0000
-46,798.0000
Total Unusual Items Excluding Goodwill
1,407.0000
2,914.0000
-913.0000
1,010.0000
62.0000
Total Unusual Items
1,407.0000
2,914.0000
-913.0000
1,010.0000
62.0000
Normalized EBITDA
-40,914.0000
-46,789.0000
-53,959.0000
-40,117.0000
-38,124.0000
12/31/2020 - 8/7/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers